News | November 29, 2023
Bayer commits to Veeva Vault CRM and Veeva OpenData globally
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Farxiga is expected to have such a strong influence on the market due to the impressive results
Viraleze was developed for application in the nasal cavity to help reduce exposure to respiratory viruses, including SARS-CoV-2. The product is registered for sale in Europe and India, and available online in certain markets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)